Protokoly_diagnostiki_i_lechenia_zabolevany

& . & & $ " "3.

J "

& $ $

& ( % %$ $ " )

" & :

1.V 100 /2

2.*; V 50 /1

3. *; V 1% 1

4.*š 5% 10 , 20

5.*7 70% ( )

" & & :

* – , # (% % ) .

7 8

: 21-172

"$ &: "

: 6!

& ! : , , "(: ;03 ' , % %

) : 7 - # % % " , / " " ; % – %

$ :

-,

-% , %

-,

" , & & , % & % , – " .

" & : " & & :

+ :

, .

" & :

1. *@ 100 &

" & & :

,- ! :

$ " %

; 8

: 02-026

"$ &: "

: 6!

& ! : & , % % , & .

(:

B00.5 " &

H16

B02.3 $# %

) : ; 8 – ( " $# )" " (" # V$), .

$ :

1.< V$

2.: ( , , ) ( V )

3.B .

( & " ).

1.! &, " , ;

2.& V ( );

3.B & " , " # - , V, , % " & ( );

4.( ,, , %

" );

5.' % " " /" (" # $# ).

" & :

1.'

2.<

3.B " &

" & & :

2.&

3.; ( & )

5.; K

6.'

7.&

8.&

9.&

10.&

11.@ " ($ , - ).

+ :

% " & " % , % " " % .& " " & , $# V .

7 & : "

( , , , , ,

6 ( ! ) " . @ & % .

" & :

1.B

3.+

4.! &

5. *? ( ) ( & ) 0,1%, 0,5%, 1% 1

6.B &

7.*+ 20

8. ? &, 200 ; 205

" & & :

" – & .

/ , & :

1.Prodigy Knowledge. Prodigy Guidance – Herpes simplex – ocular.2004.

2.! " – . ? ?>+ . ?.?. . +BB ?6+. 6 .

3.Kaufman H, Martola E, Dohlman C. Herpes simplex treatment with IDU and corticosteroids. TransAm Acad Ophthalmol Otolaringol 1963;67:695-701.

4.Sonkin P, Baratz K, Frothingham R, et al. Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty. Ophthalmology 1992;99:1805-8.

5.Liesegang T. Diagnosis and therapy of herpes zoster ophthalmicus. Ophthalmology 1991;98:1261-29.

6.Hoang-Xuan T, Buchi E, Herbort C. Oral acyclovir for herpes zoster ophthalmicus. Ophthalmology 1992; 99:1062-71

7.Wilhelmus KR. Interventions for herpes simplex virus epithelial keratitis (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software. Search Date November 2000.

8.Wilhelmus KR., Gee L., Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of

topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994; 101: 1883-1895. 9. @ & . >% " . 2003 - L & 7. - !. 2340-2349.

* – , # (% % ) .

;

: 02-023

"$ &: "

: 6!

& ! : ! % ' @ &$ # &% & , " " .

(: H40

Q15.0 ' %

) : ; – , $# " (' @),, $# "( 3 ) & .

' @: & , & ,, .

$ ' @: , ; & ,' @.

% & : " & , , , & .

"$ ( & ): , . * : . ". B$# " % . . ! .

: ' @, % , % , 3 & .! && " % % ,$# % & , " % ,, $ &, . $", ' @, , &

. + & ' @ & , $#$ ( , .), ( , ,, ) ( & , , ). 40 & ' @ & % 1 .

" & :

1.'

2.<

3.&

4.;

6.&

8.&$ ( " )

" & & :

1.;

& 3 &

1 & (0,5%). " % ' @ ( ' @ 25 . . & ) – &. ' @ –" . 3 " ( ' @) – " .

J " " & J! "

-; 0,5% ( 1 2 / ). - ( 1 1 / . " ). - ( 1 3 / ).

J! "

-< 0,25%, 0,5% ( 1 2 / ). -@ 2% ( 1 3 / ).

-@ 0,1% ( 1 2 / ). - 0,125-0,25 ( 1 3 / ). " & . J>L>+B> !; B!;H ?

- 1 0,5% % . – &" ( " & ). -B 2% % 15- , 1-24 .

" & . -'/ "$ &: 1-2 2,5% 1 2%( % ).

-@ % ' @ % & (500 / , / &), & . – & . + 3 /

3 3 & 3 -' " , & ' @ , % " & ,

$# " , / ( 2 / 20% " 30 ).! &, " 3 % &" " .

J>L>+B> @ !; B!;H ?

-3-4 1% " & " . -0,5% $ 2 &.

-' & "$ 0,25 1-3 &.

-@ % &$ 3$ 3 & 3 .

+ 3 & % « » $ " . ;' @, " .

_ : + : 1% 3

" # . ' " :

@ "& 2,0 / .

" & :

1.*;

2.* ( ) ( ) 2% 5 , 4% 10

3.< 0,25%

4.@ &

5.@ &

6.0,075 , 0,3 , 0,15

7.*G V 2,5% 2 ; 25 , 100

8.@ & % 20

9.*' 5 , 10

10.100 %

11.7 250

12.30

13.*@ "& V 40 /10%, 20%

" & & :

,- ! (! ):

- )H - ' @

1.American Academy of Ophthalmology. Guideline. Primary Angle Closure. 2000.

2.American Academy of Ophthalmology. Guideline. Primary Open-Angle Glaucoma. 2003.

3.American Academy of Ophthalmology. Guideline. Primary Open-Angle Glaucoma Suspect. 2002.

4.Prodigy Knowledge. Prodigy Guidance-Glaucoma. 2004.

5.EBM Guidelines. Glaucoma. 2004.

6.American Academy of Ophthalmology. Primary Open-Angle Glaucoma Suspect (Initial and Follow-up Evaluation). 2003.

7.ICO International Clinical Guidelines. . Primary Open-Angle Glaucoma (Initial and Follow-up Evaluation). 2005.

8.Rossetti L., Marchetti I., Orzalesi N. Randomised clinical trials on medical treatment of glaucoma: are they appropriare to

guide clinical practice? // Arch. Ophalmol/ - 1993, 111: 96-103.

9.Glaucoma Laser Trial Group. The glaucoma laser trial (GLT) and glaucoma laser trial follow-up study: results.

Am.J.Ophtalmol 1995, 120: 718-731.

10.Migdal C, Gregory W., Hitchins R., Kolker AE. Long-term functional outcome after early surgery compared with laser and

medicine in open angle glaucoma. Ophthalmology 1994, 105: 1651-1657

11.Collaborative normal-tension glaucoma study group. The effectiveness of intraocular pressure reduction in the treatment of

normal0tension glaucoma. Am.J.Ophtalmol 1998, 126: 498-505.

12.Edwards RS. A comparative study of Ocuset Pilo 40, intensive pilocarpine and low-dose pilocarpine in the initial treatment

of primary acute angle-closure glaucoma. Curr Med Res Opin 1997, 13: 501-509.

13.Evidence-Based Medicine Guidelines. DUODEMECUM Medical Publications. 2001.

* – , # (% % ) .

;

: 03-028

"$ &: "

: 6!

& ! : " ,, " , % " %

(: H66 " H66.9 ! "

$# " " % 2-6 & " $ $ . " "$ " & " , , . G " " % & %$20-60 <. % & $ %$# % % ( " , ).

G! " &3 " , %$#.

$ :

1.( )

2.G " ( , , )

* : " & ,( " & % , , " ).

: < , ,%

" & :

2.'

3.B #&$

4.? ( , ! 7)

5.; &

6."

7.V

" & & :

1. " 6 , ! , K

2.' "

3.?

+ :

7 & . $: , , , . !

" & :

1.*@ V 5 / 2

2.*? + 625 ; V 600